Method of self-administering a dopamine 2 receptor agonist
CA 2037353 A1 · Owner: Bertrand, Helene · Inventors: Bertrand, Helene
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Abstract of The Disclosure, A method of self-administering a dopamine 2 receptor agonist in the treatment of substance abuse. The method comprises the steps of administering predetermined doses of a dopamine 2 receptor agonist over predetermined time intervals until the patient's craving ceases; then determining the cumulative dosage amount administered in the previous step; administering the cumulative dosage when the patient's craving recurs; and finally, reducing the cumulative, dosage amount as the patient's craving diminishes. Preferably the dopamine 2 receptor agonist, is bromocriptine which is administered in combination with food after avoiding consumption of nicotine, cocaine, …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 28, 1991. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 28, 2011.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 28, 2013.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.